Search Results
-
Post
Medicare Issues Proposed Local Coverage Determination that Provides Coverage of Optune® for Newly Diagnosed Glioblastoma
...whether this may prevent or temporarily interfere with Optune treatment. Please see http://www.optune.com/safety to see the Optune Instructions For Use (IFU) for complete information regarding the device’s indications, contraindications, warnings,...
-
Post
Novocure’s Optune® Now Available at 500 Cancer Treatment Centers in the U.S.
...this may prevent or temporarily interfere with Optune treatment. Please see http://www.optune.com/safety to see the Optune Instructions For Use (IFU) for complete information regarding the device’s indications, contraindications, warnings, and...
-
Post
Novocure Announces Presentation of EF-19 Post-approval Registry Trial Data Studying Optune as a Monotherapy for the Treatment of Recurrent GBM at the American Association for Cancer Research 2020 Virtual Annual Meeting I
...Clinical Trials Date and Time: April 27, 2020 9:00 AM – 6:00 PM URL:https://www.abstractsonline.com/pp8/#!/9045/presentation/10602 About Optune Optune is a noninvasive, antimitotic cancer treatment for GBM. Optune delivers Tumor Treating Fields...
-
Post
First Patient Enrolled in Novocure’s Global Phase 3 TRIDENT Trial of Optune® Concurrent with Radiation Therapy in Newly Diagnosed Glioblastoma
...study in newly diagnosed glioblastoma (GBM) testing the potential survival benefit of initiating Optune concurrent with radiation therapy. Currently, Optune with maintenance temozolomide is used to treat adults with glioblastoma,...
-
Post
China National Medical Products Administration Grants Innovative Medical Device Designation for Optune® in China
...Do not use Optune in patients with GBM with an implanted medical device, a skull defect (such as, missing bone with no replacement), or bullet fragments. Use of Optune together...
-
Post
Health Care Service Corporation Issues Positive Coverage Decision for Optune
...Optune treatment. Please visit Optune.com/Safety for Optune Instructions For Use (IFU) for complete information regarding the device’s indications, contraindications, warnings, and precautions. Forward-Looking Statements In addition to historical facts or...
-
Post
Health Care Service Corporation Issues Positive Coverage Decision for Optune
...Optune treatment. Please visit Optune.com/Safety for Optune Instructions For Use (IFU) for complete information regarding the device’s indications, contraindications, warnings, and precautions. Forward-Looking Statements In addition to historical facts or...
-
Post
Novocure Receives FDA Approval for Second Generation Optune System
Second generation Optune system is less than half the weight and size of first generation Optune system New system aims to make Optune therapy even easier for glioblastoma (GBM) patients...
-
Post
Novocure Receives FDA Approval for Second Generation Optune System
Second generation Optune system is less than half the weight and size of first generation Optune system New system aims to make Optune therapy even easier for glioblastoma (GBM) patients...
-
Post
German Institute for Quality and Efficiency in Healthcare Publishes Rapid Report Noting Optune’s Survival Benefit for Patients with Newly Diagnosed Glioblastoma
...patients with newly diagnosed GBM who added Optune to standard chemotherapy, temozolomide, had a greater opportunity to live longer than those who used chemotherapy alone. Patients treated with Optune plus...